You are viewing the site in preview mode

Skip to main content

Table 1 Participant characteristics at baseline (n = 14)

From: Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness

Variable

N

%

Demographic and clinical characteristics

  

Male

12

85.7

White/Caucasian

13

92.8

Australian born

13

92.8

ATSI descent

0

-

Unemployed

13

92.8

Primary diagnosis

  

Schizophrenia

1

7.1

Paranoid schizophrenia

7

50.0

Schizoaffective disorder

4

28.6

Bipolar affective disorder

2

14.3

Prescribed medications

  

Clozapine (mean dosage; mg)a

8 (403.1)

57.1

Polypharmacy (≥ 5)a

13

92.8

High polypharmacy (≥ 9)a

11

78.6

Physical characteristics

  

Current smoking

4

28.6

Metabolic health

  

Normal weightb

1

5.9

Pre-obesity (overweight)b

5

29.4

Obesityb

11

64.7

 

M

SD

BMI

34.6

8.4

Waist circumference (cm)

120.4

15.0

Frailty Index at screening

0.35

0.08

Clinical assessments

  

Psychosis symptoms (PANSS total scale)

66.6

13.1

Physical component (SF-36)

55.6

26.1

Mental component (SF-36)

62.4

20.4

Global functioning (GAF total score)

47.8

6.1

Quality of life (AQOL-8D total score)

64.8

14.8

Physical activity (min; SIMPAQ)c

184.6

217.9

Sedentary time (min; SIMPAQ)

588.6

256.3

Fruit & vegetable intake (portions; FACET)

4.4

2.4

Sleep (PSQI global score)

6.8

4.0

  1. ATSI, Aboriginal and Torres Strait Islander; BMI, Body Mass Index; SD, standard deviation; SF-36, Medical Outcomes Scale Short Form-36; PANSS, Positive and Negative Syndrome Scale; GAF, Global Assessment of Functioning; MVPA, moderate-to-vigorous physical activity; PSQI, Pittsburgh Sleep Quality Index; SIMPAQ, Simple Physical Activity Questionnaire; FACET, Five-a-day Community Evaluation Tool; AQoL-8D, Assessment of Quality of Life
  2. a Other prescribed medications were: aripiprazole (2 participants), allopurinol (1 participant), amisulpride (1 participant), allopurinol (1 participant), brexpiprazole (1 participant), and sertraline (1 participant). Polypharmacy was defined as concurrent use of 525 and of 9 or more regular medications [26].
  3. b BMI was classified into groups based on World Health Organization classification of nutritional status.37 Among the participants with Obesity, 4 had a BMI that corresponded with ‘Obesity class I’ (23.5%) category, 3 with BMI of ‘Obesity class II’ (17.6%), and 4 whose BMI corresponded with ‘Obesity class III’ category
  4. c Physical activity was assessed using moderate-to-vigorous physical activity domain of the SIMPAQ, which includes time spent walking and time spent exercising